Clinical trial
Phase 2 Study of TLK286 in Metastatic Breast Cancer
NCT00035841 · Telik, Industry · Completed
Key facts
| NCT number | NCT00035841 |
|---|---|
| Title | Phase 2 Study of TLK286 in Metastatic Breast Cancer |
| Official title | Phase 2 Study of TLK286 in Metastatic Breast Cancer |
| Lead sponsor | Telik, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | TLK286 |
| Enrollment | 60 |
| Start date | Apr 1, 2002 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | May 7, 2002 |
| Last update posted | Jul 25, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: